Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Peak Identification by m/z Ratios – V 2.0

Posted on By

Analytical Method Development: Peak Identification by m/z Ratios – V 2.0

Standard Operating Procedure for Peak Identification by m/z Ratios in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/110/2025
Supersedes SOP/AMD/110/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the procedure for identifying chromatographic peaks using accurate mass-to-charge ratio (m/z) values in LC-MS and LC-MS/MS datasets. It facilitates structural confirmation, impurity profiling, and

degradant identification.

2. Scope

This SOP applies to all analytical activities in the Analytical Method Development (AMD) laboratory that require LC-MS or GC-MS-based peak identification using m/z data, including unknown peak investigation in stability and stress studies.

3. Responsibilities

  • Analytical Scientist: Executes m/z-based analysis, matches theoretical masses, and interprets fragmentation patterns.
  • Mass Spectrometry Specialist: Configures high-resolution MS and assists in isotopic distribution interpretation.
  • QA Officer: Verifies data quality, traceability, and compliance.
  • Head – AMD: Approves final identification reports and associated annexures.
See also  Analytical Method Development: SOP for Dosage Form De-aggregation Evaluation - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring scientifically justified, reproducible, and regulatory-aligned identification of unknown peaks by mass spectrometric analysis.

5. Procedure

5.1 Sample and Standard Preparation

  1. Prepare API, formulation, and stress-degraded samples in appropriate solvent (e.g., methanol or ACN:water 50:50).
  2. Use known reference standards wherever available.
  3. Filter through 0.22 µm PTFE filter.
  4. Document preparation details in Annexure-1: Sample Log Sheet.

5.2 Data Acquisition

  1. Set LC-MS method to high-resolution full scan (100–1000 m/z) on Q-TOF or Orbitrap system.
  2. Run in both positive and negative ion modes as applicable.
  3. Record MS and MS/MS spectra at different collision energies (10–40 eV).
  4. Acquire Total Ion Chromatograms (TIC) and Extracted Ion Chromatograms (EIC).
  5. Record parameters in Annexure-2: Acquisition Details.

5.3 m/z-Based Peak Identification

  1. Locate unknown peaks in TIC/EIC and determine exact m/z value.
  2. Compare observed m/z with theoretical m/z values of expected compounds and known impurities using:
    • Molecular formula calculators
    • Compound libraries
    • Software prediction tools
  3. Calculate mass error in ppm:
    Mass Error (ppm) = [(Measured m/z – Theoretical m/z) / Theoretical m/z] × 10⁶
  4. Accept identification if error ≤ 5 ppm and isotopic pattern matches.
  5. Log observations in Annexure-3: m/z Matching Sheet.
See also  Analytical Method Development: SOP for Syringeability and Injectability Method Development - V 2.0

5.4 Fragmentation and Structural Confirmation

  1. Use MS/MS spectra to confirm fragmentation pathways of selected m/z peaks.
  2. Propose bond cleavage logic and fragment assignments.
  3. Draw proposed structure with fragmentation arrows for reporting.
  4. Refer to known fragmentation libraries (e.g., MassBank, mzCloud).
  5. Record structural proposals in Annexure-4: Fragmentation Interpretation Sheet.

5.5 Reporting and Finalization

  1. Compile:
    • RT, m/z, theoretical vs measured values
    • Isotopic match (%)
    • Fragmentation evidence
    • Final peak assignment (known, probable, unknown)
  2. Review report with QA and mass spectrometry team.
  3. Finalize report and archive spectra, chromatograms, and annotations.
  4. Summarize in Annexure-5: Peak Identification Summary Log.

6. Abbreviations

  • m/z: Mass-to-charge ratio
  • RT: Retention Time
  • TIC: Total Ion Chromatogram
  • EIC: Extracted Ion Chromatogram
  • ppm: Parts per million
  • Q-TOF: Quadrupole Time-of-Flight
  • MS/MS: Tandem Mass Spectrometry

7. Documents

  1. Sample Log Sheet – Annexure-1
  2. Acquisition Details – Annexure-2
  3. m/z Matching Sheet – Annexure-3
  4. Fragmentation Interpretation Sheet – Annexure-4
  5. Peak Identification Summary Log – Annexure-5

8. References

  • ICH Q3A(R2) – Impurities in New Drug Substances
  • FDA Guidance for Industry: Analytical Procedures and Methods Validation
  • MassBank of North America (MoNA)
See also  Analytical Method Development: SOP for Qualification of Receiving Laboratory - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sample Log Sheet

Sample ID Matrix Solvent Prepared By Date
FDS-110-API API ACN:Water Rajesh Kumar 18/05/2025

Annexure-2: Acquisition Details

Instrument Ion Mode Range Resolution CE
Q-TOF Positive 100–1000 High 20–35 eV

Annexure-3: m/z Matching Sheet

Peak RT Observed m/z Theoretical m/z Mass Error (ppm) Status
12.8 345.1542 345.1537 1.45 Confirmed

Annexure-4: Fragmentation Interpretation Sheet

MS/MS spectra for m/z 345.1542 showed fragments at m/z 287.1, 243.1, and 121.0. Fragmentation suggests neutral losses of C2H4O and amide cleavage. Proposed structure aligns with known degradant DP-3.

Annexure-5: Peak Identification Summary Log

RT m/z Identity Evidence Type Conclusion
12.8 345.1542 DP-3 MS, MS/MS, Library Confirmed
14.2 362.1608 Unknown MS only Unidentified

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added ppm calculation, fragmentation annexure, isotopic matching logic Annual Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Stability Testing of Gel Products – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Filling and Sealing of Injectable Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version